More Than Good Science: What It Takes to Be a Successful Biotech in Today’s Financing Environment

Breakthrough data and discoveries may light the path forward, but they don’t guarantee success. In this conversation, Cooley partner Courtney Thorne, Hansa Biopharma CEO Renée Aguiar-Lucander and AviadoBio CEO Lisa Deschamps share what truly separates the companies that secure funding from those that don’t.

Learn why investor confidence hinges on more than strong science – and how strategy, storytelling, leadership and adaptability shape outcomes in today’s challenging financing environment. From building credibility and optionality to navigating pivots and partnerships, this discussion offers practical lessons for anyone driving innovation from lab to market.